Conversion from Sandimmune to Neoral in renal transplant: functional histopathological, and pharmacokinetic changes.
Department of Nephrology, Faculty of Medicine, University of Chile, Santiago, Chile.
E
E
Roessler
S
S
Herrera
M
M
Espinoza
A
A
Ayala
E
E
Reynolds
F
F
González
O
O
Espinoza
A
A
Undurraga
R
R
Muñoz
O
O
Arcos
G
G
Galaz
D000935:Antifungal Agents / Q000627:therapeutic use; D003404:Creatinine / Q000097:blood; D016572:Cyclosporine / Q000097:blood / Q000493:pharmacokinetics* / Q000627:therapeutic use*; D004347:Drug Interactions; D006085:Graft Survival; D006801:Humans; D007166:Immunosuppressive Agents / Q000097:blood / Q000493:pharmacokinetics* / Q000627:therapeutic use*; D007654:Ketoconazole / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000276:immunology* / Q000473:pathology / Q000502:physiology; D008657:Metabolic Clearance Rate; D011188:Potassium / Q000097:blood; D012964:Sodium / Q000097:blood
D000935:Antifungal Agents; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D012964:Sodium; D003404:Creatinine; D007654:Ketoconazole; D011188:Potassium